Welcome to our dedicated page for AMN HEALTHCARE SERVICES SEC filings (Ticker: AMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMN HEALTHCARE SERVICES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMN HEALTHCARE SERVICES's regulatory disclosures and financial reporting.
AMN Healthcare Services director Daphne E. Jones reported compensation-related equity activity and corrected a prior share count. She exercised 8,325 Restricted Stock Units (RSUs) into the same number of shares of AMN common stock, which are held in the Daphne E. Jones Revocable Trust. Following this transaction, the filing states she beneficially owned 16,124 shares of common stock through the trust.
On the same date, Jones received a new grant of 8,304 RSUs under the AMN Healthcare 2025 Equity Plan, each representing one future share of common stock, bringing her direct RSU holdings to 8,304 units. The amendment also notes an earlier Form 4 had overstated her post-transaction ownership by 1,000 shares, and this filing corrects that figure.
AMN Healthcare Services director Mark G. Foletta, through The Foletta Family Trust, reported open-market sales of a total of 3,681 shares of AMN common stock on June 15, 2026. The trust sold 2,000 shares at a weighted average price of $31.069 and 1,681 shares at a weighted average price of $31.067, in multiple trades within disclosed price ranges. Both sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on March 12, 2026. After these transactions, indirect holdings reported for the trust were 19,917 shares in one line and 17,917 shares in another.
AMN Healthcare Services reported a sharp turnaround in Q1 2026, driven by large labor disruption projects. Revenue doubled to $1,378.4 million from $689.5 million, led by nurse and allied solutions, which surged to $1,127.3 million as AMN staffed multiple large-scale labor disruption events.
Net income swung to a profit of $62.2 million, or $1.60 per basic share, compared with a small loss a year earlier. Operating cash flow jumped to $562.5 million, reflecting sizable client deposits and higher segment operating income, and cash and cash equivalents rose to $560.7 million with the revolving credit facility fully repaid.
While nurse and allied solutions grew 173%, physician and leadership solutions revenue declined 6% and technology and workforce solutions fell 15%, pressured by lower locum tenens volume, weaker VMS and language pricing, and the sale of the Smart Square scheduling software. Consolidated gross margin narrowed to 26.8% from 28.7% as mix shifted and technology margins compressed, partly offset by higher-margin labor disruption work.
AMN Healthcare Services reported a very strong first quarter of 2026, with revenue of $1.378 billion, up 100% from a year earlier, and net income of $62 million or $1.59 per diluted share versus a prior-year loss. Adjusted diluted EPS rose to $2.10 from $0.45, while adjusted EBITDA reached $166.1 million, a 159% increase and a 12.1% margin. Nurse and Allied Solutions revenue grew to $1.127 billion, helped by $722 million from labor disruption events, and most staffing categories showed year-over-year growth, though Physician and Leadership Solutions and Technology and Workforce Solutions declined.
Cash flow from operations was $562 million, boosting cash to $561 million against $750 million of debt and a 1.6x leverage ratio. For second quarter 2026, AMN guided consolidated revenue to $620–$635 million with operating margin around breakeven and adjusted EBITDA margin of 6.7%–7.2%, signaling a step-down from the disruption-driven Q1 peak.
Palmer Eric P reported acquisition or exercise transactions in this Form 4 filing.
AMN Healthcare Services director Eric P. Palmer received a grant of 8,304 restricted stock units (RSUs). The award was made on May 1, 2026 under the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN common stock at vesting.
The 8,304 RSUs vest on the earlier of the one-year anniversary of the grant date or the company’s 2027 Annual Meeting of Shareholders. Restricted stock units do not have an expiration date, and Palmer’s direct holdings of RSUs following this grant total 8,304 units.
Hinton James H. reported acquisition or exercise transactions in this Form 4 filing.
AMN Healthcare Services director James H. Hinton received an equity award of 8,304 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of AMN common stock under the AMN Healthcare 2025 Equity Plan.
The RSUs were granted on May 1, 2026 and vest on the earlier of the one-year anniversary of the grant date or the company’s 2027 Annual Meeting of Shareholders. At Hinton’s irrevocable election, the vested RSUs will settle in shares on the date he separates from service as a director.
Fontenot Teri G. reported acquisition or exercise transactions in this Form 4 filing.
AMN Healthcare Services director Teri G. Fontenot received a grant of 8,304 Restricted Stock Units as equity compensation. Each RSU represents a right to one share of AMN common stock. The RSUs vest on the earlier of one year from the May 1, 2026 grant date or the 2027 Annual Meeting of Shareholders, and settle upon the director's separation from service, based on her prior election.
AMN Healthcare Services director Jeffrey R. Harris acquired additional common shares through the vesting and settlement of Restricted Stock Units (RSUs). On May 1, 2026, RSU awards converted into a total of 43,063 shares of AMN common stock, with no open‑market purchases or sales reported.
The RSUs were granted under AMN equity plans, including awards from 2006–2010 and a 2025 grant. Several older RSU grants settled on May 1, 2026, which the footnotes identify as the date of the director's separation from service with the company. Following these settlements, Harris holds 67,262 shares of AMN common stock directly.
AMN Healthcare Services director Sylvia Trent-Adams reported routine equity compensation changes. On May 1, 2026, 8,325 shares of common stock were acquired upon vesting and exercise of previously granted Restricted Stock Units (RSUs) under the AMN Healthcare 2017 Equity Plan, bringing her direct common stock holdings to 16,797 shares after the transaction. The filing also shows a new grant of 8,304 RSUs under the AMN Healthcare 2025 Equity Plan, each representing one future share of common stock. These new RSUs vest on the earlier of the one-year anniversary of the May 1, 2026 grant date or the company’s 2027 Annual Meeting of Shareholders.